Evaluating the efficacy of combination and single-agent immunotherapies in real-world patterns of disease progression and survival of metastatic melanoma patients

Ko, B., Tao, K., Brennan, L., Rakhade, S., Chan, C. X., Moone, J.-Y., Zhu, R., Sher, A., Wang, S., Bracero, Y., Fullerton, B., McLellan, B., Geskin, L. J., & Saenger, Y. M. (2024). Evaluating the efficacy of combination and single-agent immunotherapies in real-world patterns of disease progression and survival of metastatic melanoma patients. Melanoma Research, 34(2), 134–141. https://doi.org/10.1097/cmr.0000000000000945
Authors:
Brian Ko
Kevin Tao
Lachlan Brennan
Swanand Rakhade
Cynthia X. Chan
Jee-Young Moone
Richard Zhu
Ariel Sher
Samuel Wang
Yadriel Bracero
Benjamin T. Fullerton
Beth N. McLellan
Larisa J. Geskin
Yvonne M. Saenger
Affiliated Authors:
Lachlan Brennan
Swanand Rakhade
Benjamin T. Fullerton
Larisa J. Geskin
Columbia Affiliation:
Subjects:
Melanoma (MeSH)
Skin Neoplasms (MeSH)
Neoplasms, Second Primary (MeSH)
Immunobiology of Dendritic Cells (OpenAlex Topic)
Cancer Immunotherapy (OpenAlex Topic)
Chimeric Antigen Receptor T Cell Therapy (OpenAlex Topic)
Author Keywords:
ctla-4
immune checkpoint inhibitors
immunotherapy
melanoma
elink
Publication Type:
Article
Unique ID:
10.1097/cmr.0000000000000945
PMID:
38181115
DOI:
10.1097/cmr.0000000000000945
Journal:
Melanoma Research
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: